-
Nuclear-Targeted Nanorods Activate STING
2026-08-25
The 2024 Journal of Controlled Release study developed PFPD, nuclear-targeted chimeric peptide nanorods that combine photodynamic DNA damage with intracellular delivery of the STING agonist DMXAA. By coupling localized reactive oxygen species generation to cGAS/STING activation, the platform enhanced innate and adaptive antitumor immunity and suppressed lung metastasis in preclinical models.
-
25-Hydroxycholesterol Reprograms TAM AMPK Signaling
2026-08-25
Xiao et al. identify CH25H-derived 25-hydroxycholesterol as an immunometabolic checkpoint that accumulates in lysosomes, alters GPR155–mTORC1 signaling, and activates AMPKα in tumor-associated macrophages. The resulting AMPKα–STAT6 pathway increases ARG1 production and immunosuppression, whereas CH25H loss improves T-cell activity and strengthens anti-PD-1 responses.
-
Deracoxib and Piroxicam in Canine Osteosarcoma Cells
2026-08-24
This in vitro study compared deracoxib and piroxicam across canine osteosarcoma cell lines and a fibroblast control, combining viability measurements with DNA-fragmentation analysis. Deracoxib showed broader and stronger concentration-dependent cytotoxicity than piroxicam, but both effects occurred above typical canine plasma concentrations and were not accompanied by detectable DNA fragmentation.
-
DDI2–NFE2L1 Proteostasis Protects Against Ferroptosis
2026-08-24
The reference study identifies DDI2-dependent activation of NFE2L1 as an adaptive proteostasis response to ferroptosis. Its genetic, proteomic, and pharmacological evidence shows that disrupting this pathway reduces proteasome activity, increases protein ubiquitylation, and sensitizes cells to oxidative lipid damage.
-
Mubritinib (TAK 165): Mapping OXPHOS Dependency
2026-08-23
Mubritinib (TAK 165) is more than a legacy HER2 inhibitor: it is a mechanistic probe of complex I–dependent oxidative phosphorylation. This guide explains how to translate its AML selectivity into rigorous metabolic, genetic, and viability assays.
-
EHEC and Danazol Models of Precocious Puberty
2026-08-22
A 2025 study evaluated an Eclipta prostrata–Hordeum vulgare extract complex (EHEC) in rat models of precocious puberty induced by Danazol or a high-fat diet. EHEC delayed vaginal opening, reduced ovarian maturation, and attenuated hypothalamic GnRH mRNA elevation without changing body weight, supporting further investigation of herbal modulation of the hypothalamic–pituitary–gonadal axis.
-
Chuanxiong Cortex and Pith: Fenipentol in CHD
2026-08-21
The reference study distinguishes the volatile chemistry and predicted pharmacology of Ligusticum chuanxiong cortex and pith using SPME-GC×GC-MS, network pharmacology, and molecular docking. Fenipentol, also known as 1-Phenyl-1-pentanol, emerged among the principal cortex-associated candidates, providing a useful hypothesis for mechanism-oriented cardiovascular and natural-product research.
-
ABT-199 Workflows for Bcl-2 Apoptosis Research
2026-08-20
ABT-199 (Venetoclax) enables mechanism-focused studies of Bcl-2 dependence, mitochondrial apoptosis, and resistance in hematologic malignancy models. This guide translates its selectivity into practical apoptosis assays, combination workflows, and troubleshooting decisions for lymphoma and AML research.
-
MHI148 Photodynamic Therapy Plus STING Activation
2026-08-20
The reference study developed GM@P nanoparticles that combine MHI148-targeted photodynamic therapy with encapsulated 2'3'-cGAMP to address breast cancer metastasis and recurrence. By coupling reactive oxygen species generation with STING-driven type I interferon induction, the platform improved dendritic-cell maturation, CD8+ T-cell infiltration, and systemic antitumor immune activity in preclinical models.
-
Nigericin Workflows for pH and Ion Transport
2026-08-19
Nigericin converts potassium–proton exchange into a practical perturbation tool for intracellular pH, mitochondrial studies, and GSDMD-linked cell death assays. This guide also shows how to translate metabolic antibiotic findings into carefully controlled ion-gradient experiments without overstating an unvalidated combination.
-
WZ4003 Workflows for NUAK1/2 Assays
2026-08-19
A scenario-driven guide to using WZ4003 (SKU B1374) in cell proliferation, migration, invasion, and tau-phosphorylation studies. It connects target-engagement controls, solvent handling, dose selection, and vendor evaluation to evidence from product data and a brain-slice reference study.
-
2'3'-cGAMP Workflow for STING and RT Studies
2026-08-18
Use 2'3'-cGAMP (sodium salt) as a defined STING-pathway benchmark, then pair it with irradiation, conditioned-media transfer, and transporter perturbation to distinguish signaling defects from cGAMP export. This workflow translates a recent radiotherapy-resistance mechanism into practical assay design for innate immunity and immunotherapy research.
-
Ceftolozane Sulfate: PK/PD Workflows for Resistant Bacteria
2026-08-18
Ceftolozane sulfate supports a connected workflow from MIC testing and time-kill experiments to animal PK/PD modeling. Its strongest research use-case is resolving exposure–response relationships in Pseudomonas aeruginosa and selected resistant Enterobacterales while distinguishing AmpC stability from carbapenemase-associated failure.
-
Remdesivir (GS-5734): Reading Polymerase Assays
2026-08-17
Remdesivir (GS-5734) is more than a broad-spectrum antiviral benchmark: its results depend on polymerase architecture, intracellular activation, and assay context. This guide connects coronavirus and filovirus evidence with new Nipah virus polymerase structures to improve experimental interpretation.
-
L-NAME Hydrochloride: NOS Inhibition Guide
2026-08-17
L-NAME Hydrochloride, also called NG-nitro-L-arginine methyl ester, is a competitive NOS inhibitor used to reduce nitric oxide synthesis in cellular and animal experiments. Its documented effects support vascular tone regulation studies, hypertension research, and mechanistic work on NO-dependent signaling, but dose and endpoint interpretation remain model-specific.